Skip to content
Search

Latest Stories

India reaches semi-finals of women's Twenty20 World Cup

Indian women reached the semi-finals of Twenty20 World Cup after beating New Zealand by three runs on Thursday (27).

India, put into bat, scored 133-8. New Zealand could only manage to get 130-6.


Indian cricket legend Sachin Tendulkar congratulated the team over the victory.

Leading India's charge was opener Shafali Verma whose 46 earned the 16-year-old her second player-of-the-match award at Melbourne's Junction Oval.

Verma and Taniya Bhatia (23) forged a half-century stand to prop up the Indian innings, aided by some sloppy catching by their opponents.

Verma, who smashed Anna Peterson for back-to-back sixes, was first dropped by Maddy Green at long on and then at midwicket by Tahuhu.

The opener eventually holed out at long-off as wickets started tumbling.

"She's giving us good starts as we expected from her," said captain Harmanpreet Kaur, who fell for her third successive single digit score.

New Zealand wobbled early in their chase after their top three, including skipper Devine, departed with the team reeling at 34-3.

Green made 24 and Katey Martin contributed 25 to arrest the slide but it was Amelia Kerr's lion-hearted 34 not out down the order which injected excitement into the contest.

Needing 16 off the last over from Shikha Pandey, Hayley Jensen and Kerr hit a boundary each and ran three singles but could not reach the target.

Defending champions Australia remained on course to be the second team from Group A to make the semi-finals after crushing Bangladesh by 86 runs in Canberra.

Electing to bat, the hosts capitalised on a blistering start from Alyssa Healy and Beth Mooney to post 189-1, the highest total at this year's tournament.

Bangladesh managed 103-9, losing three wickets in three balls, including two run-outs, in the final over.

More For You

pharmacy

The UK spends just 9 per cent of healthcare budgets on medicines while patients face growing access gaps.

iStock

UK calls for new pharmaceutical investment to strengthen life sciences

Highlights

  • UK life sciences sector contributed £17.6bn GVA in 2021 and supports 126,000 high-skilled jobs.
  • Inward life sciences FDI fell by 58 per cent from £1,897m in 2021 to £795m in 2023.
  • Experts warn NHS underinvestment and NICE pricing rules are deterring innovation and patient access.

Investment gap

Britain is seeking to attract new pharmaceutical investment as part of its plan to strengthen the life sciences sector, Chancellor Rachel Reeves said during meetings in Washington this week. “We do need to make sure that we are an attractive place for pharmaceuticals, and that includes on pricing, but in return for that, we want to see more investment flow to Britain,” Reeves told reporters.

Recent ABPI report, ‘Creating the conditions for investment and growth’, The UK’s pharmaceutical industry is integral to both the country’s health and growth missions, contributing £17.6 billion in direct gross value added (GVA) annually and supporting 126,000 high-skilled jobs across the nation. It also invests more in research and development (R&D) than any other sector. Yet inward life sciences foreign direct investment (FDI) fell by 58per cent, from £1,897 million in 2021 to £795 million in 2023, while pharmaceutical R&D investment in the UK lagged behind global growth trends, costing an estimated £1.3 billion in lost investment in 2023 alone.

Keep ReadingShow less